N/A
Completed N=667
Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care
Source: ClinicalTrials.gov NCT02698423 ↗Enrolled (actual)
667
Serious AEs
—
Results posted
Jul 2017
Primary outcomePrimary: Number of Participants Who Performed HPV Self-testing Compared to the Number of Participants Who Responded to the Invitation to Come to the Hospital for Pap Testing — 317; 307 Participants
Summary
The purpose of this study is to determine whether human-papillomavirus (HPV) self-sampling can be used as a primary screening test for unscreened women.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Performed HPV Self-testing Compared to the Number of Participants Who Responded to the Invitation to Come to the Hospital for Pap Testing |
317; 307 | — |
| SECONDARY Proportion of Women With a Positive HPV Self-test Who Underwent All the Recommended Follow-up Clinical Investigations. |
317; 307 | — |
Eligibility Criteria
Inclusion Criteria
- No previous cervical cancer screening test in the last three years
Exclusion Criteria
- pregnancy
- previous hysterectomy
Data sourced from ClinicalTrials.gov (NCT02698423). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.